Complete Filing Data
AsiaStrategy reported Stockholders Equity of $1.37 million for FY2024.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean AsiaStrategy did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 |
|---|---|---|---|
| Selling And Marketing Expense | $58.8K | $163.6K | $221.1K |
| Revenues | $17.6M | $18.8M | $14.2M |
| Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | -$3.0K | $1.4K | -$534.00 |
| Operating Income Loss | $228.4K | $526.8K | $193.5K |
| Operating Expenses | $1.2M | $845.5K | $1.1M |
| Nonoperating Income Expense | -$279.2K | -$313.9K | -$117.5K |
| Net Income Loss | -$42.2K | $196.7K | $72.0K |
| Interest Expense Nonoperating | $283.0K | $336.8K | $170.5K |
| Income Tax Expense Benefit | -$8.6K | $16.1K | $4.1K |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$50.8K | $212.9K | $76.1K |
| Gross Profit | $1.4M | $1.4M | $1.3M |
| General And Administrative Expense | $1.1M | $681.9K | $848.0K |
| Deferred Income Tax Expense Benefit | -$8.6K | -$3.1K | -$474.00 |
| Cost Of Revenue | $16.2M | $17.4M | $13.0M |
| Comprehensive Income Net Of Tax | -$45.2K | $198.1K | $71.5K |
| Income Taxes Paid Net | $38.8K | -$49.3K | $112.4K |
| Deferred Income Tax Assets Net | $159.7K | $150.2K | |
| Other Nonoperating Income | $2.1K | $22.4K | $52.8K |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|
| Stockholders Equity | $1.4M | -$591.5K | -$789.7K | -$605.7K |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $3.0M | $1.5M | $1.2M | $1.4M |
| Restricted Cash | $380.2K | $377.8K | $377.8K | |
| Repayments Of Bank Debt | $8.1M | $11.0M | $7.3M | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | $1.5M | $313.4K | -$175.9K | |
| Retained Earnings Accumulated Deficit | -$638.4K | -$596.2K | ||
| Restricted Cash Current | $380.2K | $377.8K | ||
| Property Plant And Equipment Net | $1.0K | $2.2K | ||
| Prepaid Expense And Other Assets Current | $625.5K | $539.8K | ||
| Other Receivables | $10.0K | $420.7K | ||
| Long Term Debt Current | $2.0M | $2.4M | ||
| Liabilities Current | $2.0M | $2.7M | ||
| Liabilities And Stockholders Equity | $6.6M | $5.6M | ||
| Liabilities | $5.3M | $6.2M | ||
| Inventory Net | $2.2M | $2.0M | ||
| Contract With Customer Liability Current | $14.5K | $96.2K | ||
| Common Stock Value | $11.1K | $10.0K | ||
| Assets Current | $5.8M | $4.6M | ||
| Assets | $6.6M | $5.6M | ||
| Additional Paid In Capital Common Stock | $2.0M | $1.3K | ||
| Accumulated Other Comprehensive Income Loss Net Of Tax | $377.00 | $3.4K | ||
| Accounts Payable Current | $61.8K | $277.5K | ||
| Accounts Payable And Other Accrued Liabilities Current | $14.7K | $75.5K | ||
| Repayments Of Related Party Debt | $968.9K | |||
| Deferred Costs | $639.6K |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 |
|---|---|---|---|
| Proceeds From Bank Debt | $7.5M | $10.9M | $9.2M |
| Net Cash Provided By Used In Operating Activities | -$463.0K | $1.4M | -$2.2M |
| Net Cash Provided By Used In Financing Activities | $2.0M | -$1.0M | $2.0M |
| Increase Decrease In Inventories | $161.9K | -$1.2M | $1.4M |
| Increase Decrease In Contract With Customer Liability | -$14.5K | -$93.1K | -$1.8K |
| Increase Decrease In Accrued Liabilities And Other Operating Liabilities | -$61.0K | $52.2K | -$107.6K |
| Increase Decrease In Accounts Receivable | -$148.0K | -$172.1K | $246.7K |
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $19.5K | -$689.00 | -$983.00 |
| Increase Decrease In Accounts Payable | -$216.3K | $33.9K | -$198.5K |
| Proceeds From Related Party Debt | $1.2M | $523.9K | |
| Increase Decrease In Accrued Income Taxes Payable | -$20.0K | $68.5K | -$107.9K |
| Payments For Repurchase Of Initial Public Offering | $639.6K | ||
| Increase Decrease In Prepaid Deferred Expense And Other Assets | $82.3K | $205.2K | $124.3K |
| Proceeds From Issuance Of Common Stock | $2.0M |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 |
|---|---|---|---|
| Weighted Average Number Of Shares Outstanding Basic | 20.6M | 20.0M | 20.0M |
| Weighted Average Number Of Diluted Shares Outstanding | 20.6M | 20.0M | 20.0M |
| Earnings Per Share Diluted | $0.00 | $0.01 | $0.00 |
| Earnings Per Share Basic | $0.00 | $0.01 | $0.00 |
| Common Stock Shares Authorized | 100.0M | 100.0M | |
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | |
| Common Stock Shares Outstanding | 22.2M | 20.0M | |
| Common Stock Shares Issued | 22.2M | 20.0M |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 |
|---|---|---|---|
| Provision For Doubtful Accounts | -$5.4K | -$753.00 | -$5.1K |
| Investment Income Interest | $1.7K | $488.00 | $322.00 |
| Interest Paid Net | $283.0K | $336.8K | $170.5K |
| Depreciation | $1.2K | $1.7K | $2.3K |
| Long Term Loans From Bank | $3.2M | $3.4M | |
| Stock Issued During Period Value New Issues | $2.0M | ||
| Stock Issued During Period Shares New Issues | 11.1K | ||
| Settlement Of The Sale Proceeds Of Life Insurance Policies With Amount Due To A Related Party | $817.5K | ||
| Settlement Of Dividend Distribution With Amount Due From A Related Party | $255.4K |
Most recent annual filing with the SEC: May 12, 2025
Data sourced from SEC EDGAR public filings as of August 4, 2026.